Hypothesis

3 Matching Annotations

Sep 2026
www.sciencedirect.com www.sciencedirect.com

Adoptive MAIT cell therapy for liver cancer enhanced by multimodal modulation of immune receptors and checkpoints

1
1. scibot 03 Sep 2026
  
  in Public
  
  RRID:AB_1501056
  
  DOI: 10.1016/j.medj.2026.101272
  
  Resource: (BioLegend Cat# 339005, RRID:AB_1501056)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_1501056
  
  What is this?
  
  RRID:AB_1501056
Visit annotations in context

Tags

RRID:AB_1501056

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666634026002758
Oct 2025
www.sciencedirect.com www.sciencedirect.com

A nanobody-based tri-specific NK cell engager targeting CD5 triggers antitumor immunity

1
1. scibot 09 Oct 2025
  
  in Public
  
  RRID:AB_1501056
  
  DOI: 10.1016/j.xcrm.2025.102409
  
  Resource: (BioLegend Cat# 339005, RRID:AB_1501056)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_1501056
  
  What is this?
  
  RRID:AB_1501056
Visit annotations in context

Tags

RRID:AB_1501056

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379125004823
Aug 2023
dx.doi.org dx.doi.org

NL-201 upregulates MHC-I expression and intratumoral TCR diversity, and demonstrates robust antitumor activity as monotherapy and in combination with PD-1 blockade

1
1. scibot 09 Aug 2023
  
  in Public
  
  RRID:AB_1501056
  
  DOI: 10.1158/2326-6066.CIR-22-0304
  
  Resource: (BioLegend Cat# 339005, RRID:AB_1501056)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_1501056
  
  What is this?
  
  RRID:AB_1501056
Visit annotations in context

Tags

RRID:AB_1501056

Annotators

scibot

URL

dx.doi.org/10.1158/2326-6066.CIR-22-0304